Rating: Neutral | Target price range: RMB 21.5–23.5 | Current price: RMB 23.94 (closing price, 2026-10-27) | Margin of safety: -10.2% (based on the lower bound of the base-case fair value) | Market cap: RMB 82.944 billion (total shares: 3.465 billion) | Time horizon: 6–12 months | Report date: 2026-10-27
Shuanghui is the only leader in China's hog slaughtering + meat products industry with nationwide brand recognition and a scale-driven profit cushion: net profit attributable to shareholders was flat at RMB 5.053/4.989/5.105 billion in 2023–2025; 2025 ROE was 24.0%; packaged meat products contributed about 95% of segment profit. The -7.99% decline in net profit attributable to shareholders in the first three quarters of 2026 (Q3 single quarter: -18.27%) was mainly driven by low-frequency, high-impact items such as frozen inventory impairments (RMB 502 million, double the year-ago level) and provisions for food safety fines (non-operating expenses of RMB 102 million). However, frozen inventory impairment is a recurring cost of the "stock up in low season, sell in peak season" strategy; after symmetric normalization, profit is slowly contracting at about -3% per year — profitability has not collapsed, but this is not a growth stock either. The core support for the current valuation is the high dividend payout (2025 payout ratio of 98.4%, TTM dividend yield of 6.06%), yet the first interim non-payment of dividends in five years in 2026 and a +29% increase in short-term borrowings have cracked the dividend credibility. The annual dividend proposal in the March 2027 annual report is a binary test point. The current price of RMB 23.94 is about 7% above the base-case fair value midpoint of RMB 22.4; probability-weighted fair value is about RMB 22.1, and the odds across three scenarios skew downward (-27.7% to the bear-case midpoint, +12.8% to the bull-case midpoint). Conclusion: high quality, price fair-to-full, no margin of safety. Maintain Neutral; reassess once the dividend resolution is finalized or the price falls back below RMB 21.5, the lower bound of base-case fair value.
Shuanghui's net profit attributable to shareholders was flat at RMB 5.053/4.989/5.105 billion in 2023–2025; 2025 ROE was 24.0%, and this report estimates ROIC at about 16%; packaged meat products contributing about 95% of segment profit constitutes the profit cushion. However, revenue has declined for three consecutive years, and packaged meat product sales volume fell from the 2020 peak of 1.5869 million tonnes to 1.3611 million tonnes in 2025. The platform is sustained by expense deployment and the cost tailwind of falling hog prices; the 37.05% meat products gross margin (2025) includes a cyclical component from declining hog prices — this is a value-stock leader with a high profit cushion, not a growth platform.
Key evidence:
Directly comparable peers all posted losses or marginal profits in 2025 (Longda Food, with net loss attributable to shareholders of RMB 736 million, was designated ST; Huatong Shares lost RMB 136 million; Delisi earned only RMB 4.55 million). Shuanghui's profit cushion has no rival among direct A-share peers. However, Muyuan's slaughtering business achieved its first annual profit in 2025 and scaled to 28.66 million head, so the "only" claim holds only in terms of the packaged meat products core business. The 37.05% meat products gross margin, up +1.38pp YoY, coincided with a sharp fall in hog prices and will fall in tandem as the cost tailwind recedes — the platform's "cushion" is structural, but the "thickness of the cushion" is cyclical.
The direct drivers of the -7.99% YoY decline in net profit attributable to shareholders in the first three quarters of 2026 (Q3 single quarter: -18.27%) were frozen inventory impairment of RMB 502 million (RMB 249 million in the same period last year, double) and low-frequency, high-impact items such as administrative fine provisions (non-operating expenses of RMB 102 million). However, frozen inventory impairment is a recurring cost of the "stock up in low season, sell in peak season" strategy (RMB 488/339/401/502 million respectively in the first three quarters of 2023–2026); after symmetric normalization, profit is slowly contracting at about -3% per year (consistent in direction with the -3.93% decline in adjusted net profit for the first three quarters) — profitability has not collapsed, but there is no optimistic view of "still positive growth after excluding one-offs" either. Revenue -3.85% and operating cash flow -43.06% (RMB 1.152 billion tied up in frozen inventory stockpiling) reflect genuine pressure on both revenue and cash.
Key evidence:
Methodology note: if only impairments and fines are added back to the 2026 numerator (approximately RMB 453 million after tax), normalized TTM net profit attributable to shareholders would be about RMB 5.24 billion, +2.6% YoY. But the 2025 base also included RMB 401 million of impairment, and on a symmetric basis the normalized decline is about -3%. This report anchors on the latter — "slow contraction amid stagnation" is the most honest description of profitability. Of the RMB 102 million in non-operating expenses, the portion directly attributable to this penalty is RMB 63.8066 million in net profit impact; the remainder relates to other contingencies.
The 2025 payout ratio of 98.4% (RMB 5.024 billion for the full year, TTM dividend yield 6.06%) is the core support for the current price. In 2026, the first interim non-payment of dividends in five years, short-term borrowings up +29.09% from the start of the year to RMB 12.548 billion, and a return on funds of only about 1.8% show the dividend cadence has loosened. However, controlling shareholder Rotary holds 70.33% with zero pledged shares and depends heavily on dividend cash flow (undistributed profit of RMB 8.679 billion, net cash of approximately RMB 2.3 billion per the Q3 report), and the company has repeatedly reiterated that it "persists with cash dividends as the primary form." A sharp collapse in the payout ratio is not the base case — the true binary test is in the March 2027 annual report: a full-year dividend of ≥ RMB 4.36 billion (payout ratio ≥90%) restores the high-dividend credibility; below RMB 3.5 billion (<75%) means the valuation anchor switches and the price migrates toward the bear-case range.
Key evidence:
The marginal pricers are insurance capital and dividend-index funds: among the top ten shareholders at Q3, Hong Kong Securities Clearing fell from 2.34% to 1.85% and China Securities Finance from 1.67% to 0.90%, while China Life traditional insurance and Southern Dividend Low Volatility ETF positions rose — a dividend cut means buyers retreat. The articles of association clause on "cash dividends no less than 80% of total profit distribution" is automatically satisfied under pure cash dividends and does not constitute a payout ratio floor; the true market signal threshold is the total dividend itself.
Normalized P/E is about 15.8x, below its own 5-year median of about 17.6x and the cross-industry food comparable median of about 18.1x. However, the EPV zero-growth midpoint of about RMB 20.5/share (normalized FCFE RMB 1.79/share, discount rate 8.75%; sensitivity range of about RMB 17.3–22.4, depending on whether FCFE is based on normalized net profit of RMB 5.2 billion or 6.2 billion and a discount rate of 8%–8.75%) is still below the current price; the residual of about RMB 3.5 (about 14.5%) is a combination option on dividend restoration and modest growth, contingent on the March 2027 dividend resolution and Q4 frozen inventory unwinding. Base-case fair value is RMB 21.5–23.5 (midpoint RMB 22.4); the current price is about 7% above the midpoint; probability-weighted fair value across three scenarios is about RMB 22.1; odds skew downward — this conclusion is insensitive to scenario weights (at weights of 20/50/30, the weighted fair value of about RMB 22.8 remains below the current price).
Key evidence:
The tension between "not expensive" multiples and "fair-to-full" absolute valuation stems from the earnings basis: TTM net profit attributable to shareholders of RMB 4.79 billion includes about RMB 600 million of pre-tax impairment + fine drag; normalized RMB 5.24 billion corresponds to 15.8x. The current price implies r−g ≈ 7.5% (on the RMB 6.2 billion FCFE basis), i.e., the market is betting on the dual sustainability of "a RMB 5 billion profit platform + a RMB 5 billion dividend scale" — evidence for the former is ample; the latter has just been shaken. External anchors: at the most pessimistic end, the lowest aggregated platform target price is RMB 20.3 (1 Sell rating); at the most optimistic end, the median consensus target price is RMB 30. This report's base range of RMB 21.5–23.5 is below the midpoint of both, because our earnings base (FY2026E RMB 4.64 billion) is significantly below consensus, which has not yet digested the Q3 report.
Breeding sow inventory stood at 36.02 million head at the end of Q3 2026 (-10.7% YoY, 96% of the new 37.5 million head baseline), pointing to tightening supply-demand in 2027 (timing may be delayed by slaughter weights and secondary fattening); rising hog prices will compress the slaughtering spread (H1 2026 slaughtering gross margin of 6.34% is at a high level) and raise meat products raw material costs. This report's stress test estimates a profit impact of about -RMB 600 million to -1 billion; the frozen inventory position within the company's RMB 6.699 billion inventory can be unwound at a gain as hog prices recover, with impairment reversals, providing a hedge of about +RMB 300–600 million, so the net impact will most likely narrow to about -RMB 300–700 million. Muyuan's slaughtering volume has already reached 2.18x Shuanghui's; long-term pressure on independent slaughtering is a slow-moving variable.
Key evidence:
Shuanghui's cyclical position is opposite to upstream farming: hog prices grinding at the bottom in 2026 (October foreign three-way hogs at about RMB 9.43/kg, hog-to-grain price ratio of 4.05, a Level 1 warning) is precisely the period when the slaughtering spread and meat products cost tailwind are being realized; once the reversal is confirmed, the tailwinds of both businesses recede in tandem. A downward shift in the 2027 profit midpoint is a quantifiable risk beyond the base case, but the low-cost frozen inventory stockpiled in 2026 is a hedge cushion — this is also the intent of management's stockpiling strategy.
The financial impact of the maximum-level food safety penalty in October is limited and has already been provisioned (reducing the company's 2026 net profit attributable to shareholders by RMB 63.8066 million); the case involved a small scale (910 hogs, goods value about RMB 1.7 million), vastly less severe than the 2011 clenbuterol crisis (net profit down 49%–53% that year, as cited from the earnings preannouncement). But three long-tail risks remain unclear: the impact on brand sales cannot be verified before the April 2027 annual report disclosure; the chairman and three other executives were subject to "accountability penalties to individuals" (total personal fines of RMB 56.3628 million), and the penalty determination contained elements of misleading statements; and the 2025 annual report's statement of "no penalties or rectification matters" contradicts the case lead referred in October 2025, potentially drawing regulatory attention. Another food safety incident within 6–18 months would escalate this into thesis-breaking.
Key evidence:
This case involved veterinary drug residue in by-products at a single subsidiary (lincomycin exceeding the limit by 37.5x); the company-level fine and confiscation was about RMB 72.5 million, with executive personal fines of about RMB 56.36 million (the personal portion does not flow through the listed company's P&L). Six rectification items have clear responsible parties and timelines; the Q4 cured meat peak season and Spring Festival sales period are the first observable windows, and annual report sales volume by product (sustaining ≥9% growth signals an intact brand; <5% signals damage) is the hard validation point.
| Metric | FY2023 | FY2024 | FY2025 | First Three Quarters of 2026 |
|---|---|---|---|---|
| Total operating revenue (RMB 100mn) | 600.97 | 597.15 | 594.60 | 428.10 |
| YoY | -4.2% | -0.7% | -0.43% | -3.85% |
| Net profit attributable to parent (RMB 100mn) | 50.53 | 49.89 | 51.05 | 36.42 |
| YoY | -10.11% | -1.26% | +2.32% | -7.99% |
| Adjusted net profit attributable to parent (RMB 100mn) | —¹ | 48.13 | 49.39 | 36.65 |
| Gross margin² | 17.05% | 17.90% (estimated) | 18.31% (estimated) | 19.67% (estimated) |
| Net margin attributable to parent | 8.41% | 8.35% | 8.59% | 8.51% |
| Operating cash flow (RMB 100mn) | 33.88 | 84.16 | 73.52 | 34.14 |
| Free cash flow (RMB 100mn)³ | 9.76 | 70.28 | 64.52 | 27.20 |
| Cash-like assets (RMB 100mn, period-end)⁴ | — | — | — | 79.69 (2026-09-30) |
| Interest-bearing debt (RMB 100mn, period-end) | — | 81.24 | 104.34 | 130.37 |
| Debt-to-asset ratio (period-end, estimated in this report) | — | — | 45.32% | 47.49% |
| Net debt/EBITDA | — | — | — | —⁵ |
| DPS (RMB, annual) | —¹ | 1.41 (estimated) | 1.45 (estimated) | No interim dividend for 2026 |
| Payout ratio (annual) | — | 97.9% | 98.4% | Pending FY2026 annual report (2027-03) |
| Contract liabilities (RMB 100mn, period-end) | — | 23.70 | 22.51 | 23.09 |
Notes: ¹ FY2023 adjusted profit and total annual dividend not fully anchored in this batch of materials (FY2023 final dividend of RMB 7 per 10 shares confirmed). ² Gross margin basis: FY2023 uses the annual report MD&A sales-mode basis (18.05% is the FY2025 value on the same basis); FY2024/FY2025/first three quarters of 2026 are estimated in this report from the raw figures of the consolidated income statement (total operating revenue − operating cost); the difference between the two bases is roughly ±0.3pp. ³ Free cash flow = operating cash flow − purchases of long-term assets (estimated in this report); for the first three quarters of 2026, estimated as operating cash flow 34.14 − capex 6.94. ⁴ Cash-like assets = cash 68.48 + trading financial assets 4.01 + large-denomination CDs 7.2 (Q3 report basis; excludes time deposits not separately broken out in other current assets; all-type funds on a full basis were RMB 14,342mn in 2026H1). ⁵ The company has a "both high deposits and high borrowings" net-cash structure (broad net cash ~RMB 2.3bn; conservative net debt ~RMB 5.6bn), so net debt/EBITDA would be distorted and is not presented.
Reasons for metric changes (accounts with YoY ≥±20%, all per company explanations): Operating cash flow -43.06% — the company attributed this to "stocking up in the off-season to sell in the peak season amid low hog prices," with inventory up RMB 1,152mn from the beginning of the year tying up funds (while destocking in some categories released RMB 1,381mn); asset impairment losses of RMB 502mn, doubling YoY — "increased impairments on frozen products due to market conditions"; non-operating expenses +510% to RMB 102mn — recognition of expenses for qualifying contingent events (food-safety penalties); short-term borrowings +29.09% to RMB 12,548mn — "supplementing working capital and increasing external financing"; inventory +20.76% to RMB 6,699mn — hoarding frozen products amid low-price stocking; construction in progress +297.77% to RMB 538mn — new technical upgrade projects; 2026H1 selling expenses +20.82% — advertising and promotion expenses +29.88%, partly deployed as price discounts (affecting average selling price per ton); other income -59.42% — declining government subsidies.
Business model: Slaughtering + packaged meat products as twin asset-heavy manufacturing pillars (fixed assets ~38.5% of total assets), supported by feed/farming/packaging/retail; cash-on-delivery to over 22,000 downstream distributors (22,427 at end-2025, 1mn+ retail outlets) — accounts receivable only RMB 434mn (~1% of revenue), extremely strong collection discipline. Revenue is not subscription-based, but packaged meat products carry brand-driven repeat-purchase attributes and are the profit ballast; slaughtering is a flow business trading the "live hog–pork price spread."
Cash content of earnings: OCF/net profit attributable to parent was 0.67/1.69/1.44 for 2023–2025 (three-year average 1.27), and 0.94 for the first three quarters of 2026; FCF/net profit attributable to parent was 0.19/1.41/1.26, and ~0.75 for the first three quarters of 2026. Long-term above the 0.8/0.5 warning thresholds, but volatility stems from the frozen-inventory cycle: in 2023 (stockpiling + capex peak of RMB 2,412mn), FCF/net profit was only 0.19 — a typical year of "profit turning into frozen meat." Frozen inventory is both the reservoir of this business and the source of profit swinging across periods. Government subsidies continue to taper (3.29→1.64→1.60→RMB 65mn for the first three quarters of 2026); the "subsidy water" in core earnings is being squeezed out, not expanding.
Return on capital: This report estimates FY2025 ROIC at ~16.1% (NOPAT RMB 5.16bn / invested capital ~RMB 32bn), well above the discount rate (8.75%) and the company's extremely low borrowing rates (0.58%–2.30% range, per investor-platform disclosures) — healthy capital returns; the problem is nowhere to deploy incremental capital (see next point).
Capex quality: CapEx/D&A was 0.85 in 2024 and 0.55 in 2025 (RMB 900mn vs RMB 1,630mn depreciation); ~RMB 1.3bn planned for 2026, with only RMB 694mn executed in the first three quarters. The company says capacity is sufficient with no new slaughtering capacity plans; expansion proceeds via asset-light consolidation of idle capacity (Puyang 1mn-head cooperation model). No maintenance/growth split is disclosed — investment intensity persistently below depreciation translates into free cash flow in the short term, but in the long term implies hidden risks of capacity aging and competitiveness maintenance that cannot be further disaggregated.
Red flags: ① Loosening shareholder-return policy (first-ever no interim dividend in 2026 after 26 consecutive years of dividends); ② the frozen-product "stockpile–impair–release at gain" cycle allows profit to be managed across periods (impairments rising 4.88/3.39/4.01/5.02 (RMB 100mn) from 2023 through the first three quarters of 2026); ③ both high deposits and high borrowings: cash-like assets ~RMB 14.3bn (H1 full basis) coexist with short-term borrowings of RMB 12.5bn, with a cash yield of only ~1.8% (H1 interest income RMB 129mn) — at a 6% required shareholder return, the opportunity cost of retained inefficient cash is ~RMB 600mn/year, close to 13% of FY2026E net profit; ④ normalized related-party procurement within the parent group (see Management Assessment chapter).
Consistency of words and deeds: partially delivered, commitments vague. The FY2025 annual report's outlook for 2026 was only "strive to achieve growth in operating metrics"; with revenue -3.85% and net profit attributable to parent -7.99% in the first three quarters, the growth commitment will most likely fall short. On 2026-08-31, management committed during investor research to "continuing a cash-dividend-centric profit distribution policy" and "maintaining relatively high per-ton profit for meat products in H2" — the former is discounted by the no-interim-dividend decision (annual dividend pending verification), while the latter is partially on track: first-three-quarter gross margin of 19.67% (estimated in this report), +1.5pp YoY, still improving. Overall verdict: management does not overstate, but guidance is vague; delivery depends on the annual report window.
Shareholder friendliness: historically very high, currently loosening. 26 consecutive years of cash dividends since listing; FY2024/FY2025 payout ratios of 97.9%/98.4% (DPS of RMB 1.41/1.45, estimated from total dividends); no buybacks, no equity issuance or rights offerings, no dilution from equity incentives; share count unchanged at 3.465bn shares for years — a rare "pure-dividend" company in A-shares. The 2026 interim dividend suspension is the first in five years, attributed by the company to "temporary capital arrangements" (frozen-product stockpiles tying up funds). If the annual payout ratio stays ≥90%, the friendliness verdict stands; if significantly cut, the historical dividend record can no longer be extrapolated.
Risk signals: ① Large and normalized related-party transactions — in 2025, procurement of imported pork and beef cuts from Rotex (WH Group system) totaled RMB 5,335mn, 10.99% of total purchases (total routine related-party transactions ~RMB 7,475mn); in the first three quarters of 2026, Rotex procurement of RMB 3,671mn plus RMB 1,316mn of logistics services from Wantong Shunda; imported frozen meat serves as a cost-stabilization mechanism, but pricing fairness is hard for minority shareholders to verify, and the lincomycin case exposed transmission risk from upstream supply-chain quality control. ② FY2025 annual report disclosure flaws (see Argument C6). ③ After the management transition (Wan Hongwei as Chairman), the company faced the "penalties down to individuals," with executives personally fined a combined RMB 56.36mn, damaging governance and compliance reputation. ④ The finance company (100% owned by the company) has only minor deposit/lending dealings with related parties; the annual report confirms no non-operating fund occupation.
| Segment | FY2025 Revenue | Share | FY2025 Gross Margin | 2026H1 Revenue / YoY | 2026H1 Gross Margin | Business Logic |
|---|---|---|---|---|---|---|
| Slaughtering & fresh pork products | RMB 29,250mn | 49.35% | 4.94% | RMB 12,746mn / -7.43% | 6.34% (+1.43pp) | Spread business: gross margin rises even as hog prices fall; "stabilize margins, expand volume" to grab share |
| Packaged meat products | RMB 23,527mn | 39.69% | 37.05% | RMB 12,064mn / +7.64% | 36.30% (+0.20pp) | Branded consumer goods: low hog prices = cost dividend; marketing spend for volume |
| Others (poultry/foreign trade/packaging, etc.) | RMB 12,063mn | 20.35% | 4.47% | — | — | Supporting the core; poultry chain turned profitable in 2025 |
(Including inter-segment eliminations of -9.39%; segments for the first three quarters of 2026: slaughtering revenue RMB 18,942mn, operating profit RMB 199mn; meat products operating profit RMB 4,966mn.)
Accounting red flags:
Cross-period consistency:
Current market data (price anchor: 2026-10-27 close at RMB 23.94, market cap RMB 82.944 billion): PE(TTM) 16.31x (1/3/5-year percentile 27%/17%/29%); static PE (FY2025) 16.25x (20% percentile over the past 5 years); PB approximately 3.7x (15% percentile over the past 10 years, based on measured net assets at 2026Q3); TTM paid dividend yield 6.06%. Percentile caveat: TTM earnings include roughly RMB 600 million of pre-tax impairment and fines drag; normalized PE is approximately 15.8x — the "cheap-looking" multiple percentile partly reflects the depressed 2026 profit, and should be treated as reference only, not as a headline signal of cheapness.
Peer benchmarking (PE on TTM basis, 2026-10-27): Shuanghui 16.3x / Yili 18.1x (2026H1 net profit attributable -20%) / Haitian 27.6x (the only one with steady growth, net margin 26%) / Chacha Food 17.2x (distorted multiple off a low base after the 2025 profit collapse) / Yangyuan Beverage 33.3x (passively inflated by declining profits, distorted). Among comparable samples, Shuanghui has the lowest PE and the highest ROE (24.0%) — the market is assigning a "zero-growth discount," and the valuation gap between Yili and Haitian is the "growth premium." Direct-slaughter peers (Longda / Huatong / Delisi) are loss-making or barely profitable, with no valid multiples for comparison.
What the market has already priced in: Using normalized FCFE of RMB 6.2 billion, the current price implies r−g≈7.5% — at a required return of 8.75%, the market is effectively believing in perpetual growth of roughly 1.3%–1.5%; an equivalent formulation: the current price bets on the dual sustainability of a "RMB 5 billion profit platform + RMB 5 billion annual dividend scale." The former is supported by three years of flat performance in 2023–2025 and is not absurd; the latter has just been shaken by the interim dividend suspension — the current price requires the company to "keep dividends as usual," whereas in reality the dividend cadence has already loosened.
Three-layer value (EPV): Asset value approximately RMB 6.42/share (book net assets; a light-asset brand company whose book value excludes brand value, serving only as a floor reference); EPV zero-growth central value approximately RMB 20.5/share (this report's estimate: normalized FCFE RMB 1.79/share ÷ 8.75%; sensitivity band RMB 17.3–22.4 — RMB 17.3 using net profit of RMB 5.2 billion as the FCFE basis, RMB 22.4 at an 8% discount rate), covering approximately 85% of the current price; the residual approximately RMB 3.5 (about 14.5%) is the combined option of "dividend recovery + slight growth (new channels / capture of Yurun's exiting share)." The three layers are not additive — even at the top of the sensitivity band of RMB 22.4, still below the current price, indicating that for zero-growth value the current price is already "full" and requires option realization to support it.
Three scenarios and odds:
| Scenario | Probability | Fair Value Range | Central Value | vs. Current Price | Decisive Factors |
|---|---|---|---|---|---|
| Bear | 25% | RMB 15.5–18.5 | RMB 17.3 | -27.7% | Annual payout ratio cut to 70% + 2027 hog price rebounds to RMB 18/kg + packaged meat volume -3% |
| Base | 55% | RMB 21.5–23.5 | RMB 22.4 | -6.9% | Payout ratio returns to 90% (total dividends roughly RMB 4.1–4.3 billion) + normalized earnings hold the RMB 5 billion platform |
| Bull | 20% | RMB 26–28.5 | RMB 27.0 | +12.8% | Frozen inventory released at appreciated values + food-safety impact fades + new channels / capture of Yurun's exiting share (2027 net profit attributable RMB 5.3–5.5 billion, payout ratio 98%) |
Probability-weighted fair value is approximately RMB 22.1, about 8% below the current price — the odds are asymmetric and skewed to the downside; to the base fair value range -10.2%~-1.8%, to the bear case range -35.3%~-22.7%, to the bull case range +8.6%~+19.0%. Base-case exit multiple anchor: normalized RMB 5.05 billion × 16x (one notch below the 5-year median PE of 17.57x, reflecting three consecutive years of negative revenue growth; primary anchor is FCFE discounting, independent of the company's current multiple) ≈ RMB 23.3, cross-checked consistently with the FCFE-based RMB 22.4. The bear case is constructed from independent stress assumptions; the most pessimistic external anchor (lowest aggregate-platform target price of RMB 20.3) is above this bear-case range — the difference lies in this bear case layering dividend-ratio collapse with 2027 cost reversal double pressure, while the external anchor does not normalize 2026's one-off drag.
In-house earnings forecast (earnings reconciliation anchor): FY2026E revenue RMB 56.8–57.9 billion (-4.3%~-2.6%), net profit attributable RMB 4.24–4.94 billion (base RMB 4.64 billion, roughly -9%); FY2027E revenue RMB 58.0–60.2 billion, net profit attributable RMB 4.4–5.0 billion (base roughly RMB 4.7 billion). Divergence from sell-side consensus (FY2026 net profit roughly RMB 5.5 billion): we extrapolate from actual Q3 results and believe Q4 frozen-inventory release only partially offsets; consensus has not yet updated for Q3 data.
Conclusion: Fair to fully priced (fair). Assess quality and price separately — quality is excellent (ROE 24%, 26-year dividend history, the industry's only profit cushion), but the price has fully or even prematurely priced in the continuation of the "high dividend + slight growth" assumption, with no margin of safety (base fair value floor of RMB 21.5 is -10.2% versus the current price). The realization conditions of the base case (payout ≥90% + earnings platform holding) are unverifiable before March 2027, and during the wait there is a risk of downward consensus revisions.
Industry size: China's pork end-market — 2025 pork output of 59.38 million tonnes (National Bureau of Statistics, 59% of total pork, beef, mutton, and poultry meat output), hog slaughter of 719.73 million head; roughly estimated at average carcass prices, terminal market value of approximately RMB 1.0–1.2 trillion (this report's estimate). But the era of volume growth is over: per-capita pork consumption was 28.1 kg in 2024 and 26.6 kg per household member in 2025 (-5.4% YoY, Ministry of Agriculture and Rural Affairs basis); pork's share of meat consumption fell from 62% in 2018 to about 58% (Xinhua / Chinese Academy of Agricultural Sciences), with poultry, beef, and mutton substitution and demographic structure as long-term headwinds. Structurally there is K-shaped divergence: ambient-temperature ham sausage retail peaked in 2015 at roughly RMB 48 billion and has since kept shrinking (Euromonitor, cited via Jiemian News, 2026-10); processed meat overall posted a 2021–2026E CAGR of roughly 5.4% (Euromonitor), with growth concentrated in chilled, frozen, and snackified sub-categories and new channels such as snack discount stores, membership stores, and content e-commerce (Nielsen IQ's top five growth channels in 2025H1). Shuanghui operates not in a growing industry, but in one of "shrinking total volume, shifting structure, and rising concentration."
Value chain and profit distribution: Upstream hog farming (Muyuan / Wens / New Hope, 730 million head slaughtered in 2025) → midstream slaughtering (Shuanghui: 20 bases, single-shift capacity of 26 million+ head, actual slaughter of 13.14 million head in 2025, utilization about 50%) → downstream packaged meat and channels. Profit distribution is highly asymmetric: Shuanghui's packaged-meat gross margin 37.05% vs. slaughtering 4.94% vs. Longda slaughtering -0.74% in 2025 — value accrues mainly to the branded packaged-meat segment; slaughtering earns turnover and spread. Upstream bargaining power: hog prices are fully market-driven; Shuanghui, with its scale procurement plus the Smithfield imported frozen-meat related-party channel (RMB 5.335 billion in 2025) plus futures hedging to smooth costs, is the industry's only player with a global cost-hedging mechanism. Downstream, it maintains a cash-before-delivery, strong position over distributors via brand and cold chain (30+ bases across 18 provinces, 1 million+ retail outlets).
Supply-demand and competitive landscape: The supply side is undergoing two rounds of capacity clearing — (1) Farming: breeding sow inventory declined from 39.61 million head at end-2025 to 36.02 million head at end-2026Q3 (-10.7%, 96% of the new 37.5 million head baseline); farming has been loss-making for over 11 consecutive months; with a 10–12 month transmission, supply-demand should tighten in 2027. (2) Slaughtering: under policy-driven capacity reduction, the share of above-scale designated slaughtering rose from 30.9% in 2020 to 57.2% in 2025 (Ministry of Agriculture and Rural Affairs); against the US CR4 of roughly two-thirds, there remains nearly double the headroom for concentration. But competitive intensity is simultaneously rising: integrated farming giants like Muyuan are pressing downstream with cost advantages (Muyuan slaughtered 28.66 million head in 2025, doubling YoY, topping the industry for the first time with annual profitability, and up another +51% in 2026H1), squeezing independent slaughterers' profit pool; on the packaged-meat side, the structure is consolidating favorably — Shuanghui holds 60%+ offline share in ambient ham sausage vs. Jinluo's 18–20%; Yurun officially exited high-temperature packaged meat in 2026, with Shuanghui capturing its exiting share. On demand, pork imports have declined for 5 consecutive years (2.1659 million tonnes in 2025, -5.5%), strengthening the domestic self-sufficiency loop; the Ministry of Commerce imposed anti-dumping duties on EU pork from December 2025, raising the overall imported-cost baseline (indirect impact on Shuanghui's US sourcing).
Cycle and regulation: The hog cycle is currently in the latter half of a deep bottoming process — October external three-way hogs at roughly RMB 9.43/kg (about -30% YoY), hog-to-grain price ratio at 4.05, triggering the NDRC's Level-1 warning, with central reserve purchasing already initiated; leading indicators (breeding sow inventory leading hog prices by roughly 10–12 months, piglet prices, average slaughter weight / secondary fattening) all point to a 2027 reversal, though the high average slaughter weight of 128.7 kg and secondary fattening could push the tightening point later. Three regulatory threads: slaughter regulation (designated slaughtering + three-year action to cut outdated capacity, favoring leaders' share); capacity control (normal breeding sow inventory cut from 39 million to 37.5 million head in May 2026, green band narrowed, dampening cycle amplitude); tightened food-safety enforcement (the maximum penalty against Shuanghui in this case is itself a signal — for leaders, it is both a tail risk and a reinforcement of competitive barriers).
Peer benchmarking (FY2025 annual report basis):
| Company | Revenue | Growth | Net Profit / Earnings | Slaughter Scale | Key Difference vs. Shuanghui |
|---|---|---|---|---|---|
| Shuanghui Development | RMB 59.460 bn | -0.43% | RMB 5.105 bn, ROE 24.0% | 13.14 million head | Only player with both a "branded packaged-meat profit cushion + nationwide cold-chain channel" |
| Longda Food (ST) | RMB 10.019 bn | -8.83% | -RMB 736 mn (ST'd) | One of Shandong's slaughtering leaders | Inverted structure: slaughtering ~80% of revenue, no brand premium segment, governance crisis |
| Huatong Group | RMB 8.072 bn | -11.22% | -RMB 136 mn (swing to loss) | Zhejiang integrated "farming + slaughtering" | High leverage from self-raised, self-slaughtered model; becomes a drag when hog prices fall |
| Delisi | RMB 3.147 bn | +6.16% | RMB 4.55 mn (near breakeven) | Regional | Regional player in chilled packaged meat / prepared dishes, validating the industry's scale barriers |
| Muyuan Foods (upstream integration) | — (#1 in farming globally) | — | Farming-led | 28.66 million head (first to surpass Shuanghui) | Self-supplied raw materials, volume-compensating-price; Shuanghui's biggest structural threat in slaughtering |
Company positioning within the industry: A share-harvesting leader in a mature, shrinking industry. Packaged meat: national #1 with rising share (ham sausage 60%+, Yurun's exit, 2026H1 volume +9.1% returning to dual growth in volume and profit); moat = brand (brand value RMB 87.2 billion) + cold-chain network + distributor depth, with share trending up. Slaughtering: brand #1 but volume overtaken by Muyuan (13.14 vs. 28.66 million head), holding a defensive stance of "defending spreads, asset-light consolidation." The company overall exhibits counter-cyclical hog-cycle properties (low hog prices = simultaneous improvement in slaughter spreads and packaged-meat cost tailwind), with earnings volatility far smaller than upstream players and second-tier peers — in 2025, both Longda and Huatong were loss-making while Shuanghui's ROE was 24%, a living footnote to the industry's profit distribution structure.
Overall view: Neutral (confidence 0.55, horizon 6–12 months). Shuanghui is a "high-profit-cushion incumbent leader + bond-like" asset: on quality, ROE 24%, cash flow persistently above profit, and a 26-year dividend history make it among the most certain names in A-share food; on price, the current RMB 23.94 is already about 7% above the base fair value central estimate of RMB 22.4 and above the probability-weighted fair value of roughly RMB 22.0, with a margin of safety of -10.2% (base fair value floor basis) — the market has already paid a fair-to-full price for "dividends as usual + earnings platform," and verification of one of those two pillars (dividends) will not come until March 2027. Strategy: do not chase, do not short. Existing holders can hold through the dividend resolution; incremental capital should wait for one of two entry signals — price falling below RMB 21.5 (base fair value floor, odds turning positive), or the annual report confirming total dividends ≥ RMB 4.36 billion (payout ratio ≥90%, repair of the high-dividend credit).
Core risks (ranked by damage potential): (1) Annual payout ratio significantly below 90% (total dividends < RMB 3.5 billion would break the high-dividend thesis; valuation migrates toward RMB 15.5–18.5); (2) post-2027 hog-price reversal, two-way cost squeeze (net impact -RMB 300 to -700 mn) plus additional Q4 frozen-inventory impairments (if hog prices step down again, an additional single-quarter charge of RMB 250–500 mn); (3) food-safety long tail (damaged sell-through, regulatory inquiries, a repeat offense would break the thesis); (4) structural slow variables: Muyuan's integration squeezing the slaughter profit pool and long-term category shrinkage.
Monitoring points and timetable: December 2026 — sell-through in the cured-meat peak season and whether hog prices stabilize and rebound (external three-way hogs holding above RMB 11/kg, hog-to-grain ratio back above 5:1); monthly breeding sow inventory (three consecutive months ≤37.0 million head confirms reversal); late March 2027 — annual report and annual dividend proposal (total dividends ≥ RMB 4.36 bn / < RMB 3.5 bn as a binary signal), whether inventory balance declines from RMB 6.699 billion, whether asset impairments narrow or reverse; April 2027 — annual report product-level volumes (packaged meat growth ≥9% signals brand intact, <5% signals damage); regulatory rectification acceptance / re-inspection announcements and sampling pass rates. On the shareholder structure front, there are currently no unlock events, no pledged-share forced sales, no major-shareholder selling pressure, and shareholder accounts are slightly concentrating — not an additional variable.
Data and basis notes: Price anchor is the 2026-10-27 close of RMB 23.94; financial data come from the company's periodic reports (FY2023–FY2025 annual reports, and 2026 Q1 / interim / Q3 reports); balance-sheet stock data as of 2026-09-30 (Q3 report); gross margins, free cash flow, ROIC, EPV, and scenario fair values are this report's estimates, with bases noted in the text; sell-side consensus comes from market expectation aggregation (as of 2026-10-27, not yet reflecting the Q3 report disclosed on the evening of 2026-10-27).